New randomized controlled trial confirms low-dose Q-actin™ supports joint comfort and function
IminoTech today announced results from a new randomized, double-blind, placebo-controlled clinical trial showing that Q-actin™ (cucumber extract standardized to idoBR1) at 20 mg/day significantly improved joint comfort and function in adults with mild–moderate joint pain over 60 days. The study, … Read More










